Inari Medical Inc (NARI)
50.01
+0.21
(+0.42%)
USD |
NASDAQ |
Jul 03, 16:00
Inari Medical Research and Development Expense (Annual): 87.53M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 87.53M |
| December 31, 2022 | 74.22M |
| December 31, 2021 | 51.02M |
| Date | Value |
|---|---|
| December 31, 2020 | 18.40M |
| December 31, 2019 | 7.22M |
| December 31, 2018 | 3.99M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
7.22M
Minimum
2019
87.53M
Maximum
2023
47.68M
Average
51.02M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Conmed Corp | 52.60M |
| SI-BONE Inc | 15.03M |
| Stereotaxis Inc | 10.27M |
| Electromed Inc | 0.916M |
| Myomo Inc | 2.636M |